MYCN and cancer: The retinoid 13-cis-RA (13-cis-RA, isotretinoin), an isomer of ATRA, is a cancer chemoprevention drug that causes differentiation, decreased proliferation and inhibition of MYCN expression in progressive neuroblastoma cells.